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osting by EAbstract The present study was conducted to investigate the cytogenetic effects of sildenaﬁl citrate
in SWR/J mouse bone marrow cells. Thirty-six males and 36 females were used and divided into
four groups. Each group contained 18 animals (9 males and 9 females), weighing 30–35 g. These
animals were orally administered with a single dose of 13, 26 or 40 mg/kg sildenaﬁl citrate solution.
A control group received normal saline in an identical condition. The animals were sacriﬁced at 12,
24 or 48 h, after the treatment. Chromosome aberrations were investigated in 50 metaphases per
animal.
No signiﬁcant differences in the percentages of mitotic indices or in the frequencies of chromo-
some aberrations were observed between treated male and female mice at any doses or at any time
intervals used, therefore, data from the two sexes were pooled when analyzed statistically.
No signiﬁcant (p< 0.05) differences in the percentages of mitotic indices or in the frequencies of
chromosome aberrations were observed between sildenaﬁl citrate-treated groups and the control
group at any doses or at any time intervals used. However, the percentages of centromeric adhe-
sions increased signiﬁcantly (p< 0.01) in treated groups as compared with the control group at
all doses and at all time intervals used.
In conclusion, the results of the present study suggest that sildenaﬁl citrate does not have cyto-
genetic effects on mouse bone marrow cells, but the centromeric adhesions induced by this drug
need further studies to conﬁrm them and to investigate the possible mechanism(s) responsible for
such effect.
ª 2010 King Saud University. All rights reserved.75762; fax: +966 4678514.
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lsevier1. Introduction
Sildenaﬁl citrate (Viagra) is an oral medication used to treat
male erectile dysfunction. It is a cyclic guanosine-speciﬁc
phosphodiesterase (PDE) type 5 inhibitor that prevents the
metabolism of cGMP which produces arterial smooth muscle
relaxation within the corpora cavernosa of the penis and
ultimately enhances penile tumescence (Krenzelok, 2000; Ji
et al., 2005; Padma-Nathan, 2006). Sildenaﬁl citrate has
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316 F.M. Abou-Tarboush, M.F. Abdel-Samaddemonstrated effectiveness in men with erectile dysfunction
associated with prostatectomy, radiation therapy, diabetes
mellitus, certain neurologic disorders and drug therapy
(Boyce and Umland, 2001). It is also used in the treatment
of pulmonary arterial hypertension and it could be an
alternative in the treatment of intrauterine growth retarda-
tion and premature delivery (Derchi and Forni, 2005;
Villanueva-Garcia et al., 2007). Moreover, there is now ro-
bust evidence that its use in recreation has gained credence
in young healthy males as a sexual enhancer as well in older
men requiring it for importance problems (Vatansever et al.,
2003; Smith and Romanelli, 2005; Glenn et al., 2009).
The widespread use of sildenaﬁl citrate is of concern, be-
cause it is a selective type 5 phosphodiesterase inhibitor and
the phosphodiesterase inhibitors have been shown to affect
sperm function and embryo development (McKinney et al.,
1994; Scott and Smith, 1995; Glenn et al., 2009). Furthermore,
to the best of our knowledge, there is only one report concern-
ing with the cytogenetic effect of this drug on experimental ani-
mals (Lemus-Varela et al., 2006).
It is therefore imperative that the cytogenetic effects of sil-
denaﬁl citrate be investigated before it is incorporated withoutTable 1 Effect of various doses of sildenaﬁl citrate (Viagra)
on the mitotic index (MI) in bone marrow cells of SWR/J mice
after 12 h of treatment.
Dose
(mg/kg)
No. of females
used
No. of cells
examined
No. of dividing
cells
Mitotic
index (%)
Control 6 6000 244 4.07
13 6 6000 233 3.88
26 6 6000 240 4.00
40 6 6000 232 3.87
Table 2 Effect of various doses of sildenaﬁl citrate (Viagra)
on the mitotic index (MI) in bone marrow cells of SWR/J mice
after 24 h of treatment.
Dose
(mg/kg)
No. of females
used
No. of cells
examined
No. of dividing
cells
Mitotic
index (%)
Control 6 6000 253 4.22
13 6 6000 259 4.32
26 6 6000 251 4.18
40 6 6000 241 4.02
Table 3 Effect of various doses of sildenaﬁl citrate (Viagra)
on the mitotic index (MI) in bone marrow cells of SWR/J mice
after 48 h of treatment.
Dose
(mg/kg)
No. of females
used
No. of cells
examined
No. of dividing
cells
Mitotic
index (%)
Control 6 6000 258 4.30
13 6 6000 238 3.97
26 6 6000 242 4.03
40 6 6000 244 4.07
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Table 5 Effect of various doses of sildenaﬁl citrate (Viagra) on the chromosomal aberrations in bone marrow cells of SWR/J mice after 24 h of treatment.
Dose (mg/kg) No. of animals
used
No. of cells
examined
No. and types of numerical
chromosomal aberrations
No. and types of structural
chromosomal aberrations
Hypoploidy
(2n)
Hyperploidy
(2n+)
Total B CA Cad G F Total
No. % No. % No. % No. % No. % No. % No. % No. % No. %
Control 6 300 – – 2 0.7 2 0.7 1 0.3 1 0.3 2 0.7 – – 1 0.3 5 1.7
13 6 300 – – 5 1.7 5 1.7 – – 3 1.0 14 4.7** – – 1 0.3 18 6.0**
26 6 300 3 1.0 1 0.3 4 1.3 – – 4 1.3 18 6.0** – – – – 22 7.3**
40 6 300 2 0.7 3 1.0 5 1.7 2 0.7 5 1.7 22 7.3** – – 2 0.7 31 10.3**
B = break, CA= centromeric attenuation, Cad = centromeric adhesion G= gap F = fragment.
** Differences are statistically signiﬁcant from the control group at p< 0.01.
Table 6 Effect of various doses of sildenaﬁl citrate (Viagra) on the chromosomal aberrations in bone marrow cells of SWR/J mice after 48 h of treatment.
Dose (mg/kg) No. of animals
used
No. of cells
examined
No. and types of numerical chromosomal
aberrations
No. and types of structural chromosomal aberrations
Hypoploidy
(2n)
Hyperploidy
(2n+)
Total B CA Cad G F Total
No. % No. % No. % No. % No. % No. % No. % No. % No. %
Control 6 300 – – 2 0.7 2 0.7 1 0.3 1 0.3 2 0.7 – – 1 0.3 5 1.7
13 6 300 2 0.7 5 1.7 7 2.3 – – 6 2.0 14 4.7** – – 1 0.3 21 7.0**
26 6 300 – – 4 1.3 4 1.3 2 0.7 8 2.7 20 6.7** – – 2 0.7 32 10.7**
40 6 300 – – 5 1.7 5 1.7 4 1.3 3 1.0 24 8.0** 2 0.7 2 0.7 35 11.7**
B = break, CA= centromeric attenuation, Cad = centromeric adhesion G= gap F = Fragment.
** Differences are statistically signiﬁcant from the control group at p< 0.01.
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318 F.M. Abou-Tarboush, M.F. Abdel-Samadcaution into routine clinical use. So, the aim of the present
study was to investigate the possible cytogenetic effects of this
drug on SWR/J mouse bone marrow cells.
2. Materials and methods
Inbred SWR/J mice, 10–12 weeks old and weighing 30–35 g
were used throughout the study. Animals were kept and bred
in an environmentally controlled room at a temperature of
22 ± 1 C, a relative humidity of 45 ± 5% and a light/dark
cycle of 10/14 h. Rodent chow (commercially available in Sau-
di Arabia) and water were offered ad libitum. A total of 36
males and 36 females were used and divided into 4 groups,
each group contained 18 animals (9 males and 9 females). Ani-
mals of groups II–IV were orally treated with a single dose of
13, 26 or 40 mg/kg body weight of sildenaﬁl citrate (Plizer Inc.,
New York, USA), which correspond to 2, 4 or 6 times human
equivalent 50 mg, dissolved in sterile normal saline. Animals
of group I were similarly treated with the vehicle only
(0.4 ml sterile normal saline) and served as a control group.
The animals were killed by cervical dislocation 12, 24 or
48 h following the treatment and the cytogenetic effects of
the drug on those animals were evaluated using in vivo bone
marrow cells.
The methods of Adler (1984) and Preston et al. (1987) were
used for chromosome preparations. A minimum of 10 slidesFigure 1 Photomicrograph of mouse bone marrow cells at normal m
showing the centromeric adhesions (Cad), observed in sildenaﬁl-treatewere prepared and 50 well spread and distinctly identiﬁable
metaphases from each mouse were selected. Each selected
metaphase was examined using the 100· oil immersion objec-
tive of a Zeiss microscope for detecting possible chromosome
aberrations. Prior to scoring the drug effect on the chromo-
somes, the slides were covered and coded. The chromosome
aberrations scanned were: chromatid gaps (G), chromatid
breaks (B), fragments (F), centromeric attenuations and adhe-
sions (Cad), hypoploidy and hyperploidy. Photomicrographs
of selected metaphases were taken under bright illumination
using 100· oil immersion objective and 10· eyepiece.
The data obtained were statistically analyzed using a 2 · 2
contingency table (X2) (Sokal and Rohlf, 1981).
3. Results
In the present study, no signiﬁcant differences in the percent-
ages of mitotic indices or in the frequencies of chromosome
aberrations were observed between sildenaﬁl citrate-treated
male and female mice at any dose levels or at any time intervals
used. Accordingly, the data obtained from the two sexes were
pooled together and statistically analyzed.
Data in Tables 1–3 show no signiﬁcant differences
(p> 0.05) between sildenaﬁl citrate-treated groups and the
control group in the percentages of mitotic indices of bone
marrow cells at any dose levels or at any time intervals usedetaphase stage, (2). In metaphase images, (1), (3) and (4) arrows
d animals.
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any signiﬁcant differences in the percentages of polyploidy and
fragments in bone marrow cells between sildenaﬁl citrate-trea-
ted groups and the control group at any doses or at any time
intervals used.
However, data in Tables 4–6 and Fig. 1 show that the per-
centages of centromeric adhesions in bone marrow cells are
highly signiﬁcantly increased (p< 0.01) in sildenaﬁl citrate-
treated groups as compared with the control group at all doses
and at all time intervals used in the present study.
4. Discussion
The present results clearly demonstrate that a single oral
administration of 13, 26 or 40 mg/kg body weight of sildenaﬁl
citrate does not have any signiﬁcant effects on the mitotic indi-
ces or on the induction of chromosomal aberrations (both
numerically and structurally) in proliferative cells of the bone
marrow of SWR/J mice. Our results are in an agreement with
the reported non-effective role of sildenaﬁl citrate in the induc-
tion of signiﬁcant micronuclei in Callithrix jacchus, a primate
model (Lemus-Varela et al., 2006). But, to the best of our
knowledge, no other studies have been conducted to evaluate
the cytogenetic effects of this drug in other experimental
animals.
However, all dose levels of sildenaﬁl citrate signiﬁcantly in-
creased the percentages of centromeric adhesions in bone mar-
row cells of sildenaﬁl citrate-treated groups at all time intervals
used in the present study. And again, to the best of our knowl-
edge, no other reports have been documented concerning with
such effect for this drug. Therefore, further studies are needed
to conﬁrm our results and to investigate the mechanism(s)
responsible for the induction of centromeric adhesions. How-
ever, centromeric adhesions could well be related to a speciﬁc
afﬁnity of sildenaﬁl citrate for A–T base pairs in the A–T rich
repetitive DNA heterochromatin of the pericentromeric regions
of the chromosomes (Kusyk andHsu, 1976). Such afﬁnity could
render these regions to be more susceptible to adhere to each
other giving rise to such effect. However, further studies are
needed to elucidate the real mechanism(s) underlie this effect.
5. Conclusions
The present results suggest that sildenaﬁl citrate does not have
cytogenetic effects on mouse bone marrow cells. However, the
centromeric adhesions induced by this drug need further stud-
ies to conﬁrm them and to investigate the possible mecha-
nism(s) responsible for this effect.Acknowledgements
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